E72.3 Disorders of lysine and hydroxylysine metabolism

Name of the Condition

• Disorders of lysine and hydroxylysine metabolism (ICD-10 Code: E72.3)

Summary

Disorders of lysine and hydroxylysine metabolism are rare genetic conditions affecting the body’s ability to process lysine and hydroxylysine, essential amino acids involved in protein synthesis and collagen formation. These disorders disrupt metabolic pathways, potentially leading to the accumulation of toxic byproducts or deficiency of essential compounds. Clinical effects vary depending on the specific defect but may involve neurological, musculoskeletal, or systemic impairment.

Causes

These disorders are primarily caused by genetic mutations that impair enzymes or transport proteins involved in lysine and hydroxylysine metabolism. Most are inherited in an autosomal recessive pattern, requiring two mutated copies of a gene for the condition to manifest. The mutations disrupt normal biochemical pathways, leading to abnormal amino-acid levels or byproduct accumulation.

Risk Factors

• Family history of lysine or hydroxylysine metabolism disorders.
• Consanguinity (parents who are close relatives) increasing the likelihood of inheriting recessive mutations.
• Ethnic or geographic prevalence of specific genetic variants in certain populations.

Symptoms

• Neurological symptoms such as developmental delays, seizures, or intellectual disability.
• Musculoskeletal issues like joint hypermobility or connective tissue abnormalities.
• Gastrointestinal symptoms including vomiting, poor feeding, or failure to thrive.
• Hepatic or renal dysfunction in severe cases.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, biochemical testing (e.g., amino acid profiling in blood or urine), and genetic testing to identify specific mutations. Imaging studies may be used to assess organ involvement, and enzyme activity assays can confirm metabolic pathway disruptions.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This may include dietary modifications (e.g., restricted lysine intake), supplementation with missing compounds, and medications to reduce toxic byproduct accumulation. Supportive care for neurological or systemic symptoms is often necessary.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the disorder and the timeliness of intervention. Early diagnosis and treatment can improve outcomes, but some cases may result in long-term disability. Regular follow-up with metabolic specialists, neurologists, and other relevant providers is essential to monitor progression and adjust management.

Complications

Potential complications include irreversible neurological damage, growth failure, organ dysfunction (e.g., liver or kidney), and increased risk of metabolic crises. Untreated or poorly managed cases may lead to life-threatening events.

Lifestyle & Prevention

Lifestyle modifications may include adhering to prescribed dietary restrictions and avoiding triggers that exacerbate symptoms. Genetic counseling is recommended for families to understand recurrence risks and options for future pregnancies.

When to Seek Professional Help

Seek immediate medical attention for symptoms such as severe vomiting, lethargy, seizures, or signs of metabolic crisis. Regular follow-up with healthcare providers is necessary to monitor condition progression and adjust treatment plans.

Tips for Medical Coders

When coding for E72.3, ensure documentation supports the diagnosis of lysine or hydroxylysine metabolism disorders, including clinical findings, biochemical test results, and genetic confirmation if available. Code to the highest level of specificity based on the patient’s condition and documented details.